SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-054038
Filing Date
2005-11-09
Accepted
2005-11-09 15:29:37
Documents
7
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-18132_110q.htm 10-Q 762613
2 MATERIAL CONTRACTS a05-18132_1ex10d36.htm EX-10.36 39505
3 MATERIAL CONTRACTS a05-18132_1ex10d37.htm EX-10.37 231321
4 302 CERTIFICATION a05-18132_1ex31d1.htm EX-31.1 12967
5 302 CERTIFICATION a05-18132_1ex31d2.htm EX-31.2 13219
6 906 CERTIFICATION a05-18132_1ex32d1.htm EX-32.1 4838
7 906 CERTIFICATION a05-18132_1ex32d2.htm EX-32.2 4664
  Complete submission text file 0001104659-05-054038.txt   1070572
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 051189774
SIC: 2835 In Vitro & In Vivo Diagnostic Substances